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Objective: The optimal management of congenital adenomatoid malformation of the lung remains controversial.
Prenatal ultrasonographic analysis has increasingly discovered asymptomatic lesions, raising questions about the
need for and timing of surgical treatment for asymptomatic congenital adenomatoid malformation. The aim of our
study was to analyze the short-term postoperative outcome of symptomatic congenital adenomatoid malforma-
tions compared with asymptomatic malformations.
Methods: All the data of patients presenting with congenital adenomatoid malformations histologically diag-
nosed and operated on between 1998 and 2005 at our institution were retrospectively reviewed. Patients were
divided into 2 groups: group A comprised asymptomatic infants, and group B comprised symptomatic infants.
Major outcomes considered were the length of ventilation, pleural drainage, and hospital stay. Postoperative mor-
bidity and mortality were also evaluated. Asymptomatic patients were further stratified for age at the time of the
operation to evaluate whether age at surgical intervention affects the outcome. The Fisher’s exact and Mann–
Whitney tests were used as appropriate.
Results: Fifty-seven patients were consecutively treated. Thirty-five patients were given diagnoses of asymptom-
atic lesions and were enrolled into group A, whereas 22 patients presenting with symptoms were entered into
group B. The lengths of ventilation, pleural drainage, and hospital stay were significantly longer in patients
with symptomatic congenital adenomatoid malformations. Moreover, symptomatic patients presented with
a higher postoperative complication rate. The age-based stratification of asymptomatic children did not show
any difference on either postoperative mortality or major outcome considered.
Conclusion: Children with congenital adenomatoid malformations operated on when asymptomatic present
a better short-term outcome than symptomatic children. In addition, age at the time of the operation does not nega-
tively affect the outcome. Our findings support early surgical treatment for asymptomatic congenital adenomatoid
malformation.Congenital cystic adenomatoid malformation of the lung
(CCAM) is a relatively rare developmental defect of the
lung. The exact cause is not completely understood.1
CCAM is usually diagnosed prenatally by means of rou-
tine ultrasonographic analysis, is typically unilateral, and
involves only a single lobe of the lung. An entire range of
different clinical courses was reported for antenatally diag-
nosed CCAMs, varying from fetal hydrops and neonatal
demise to complete prenatal spontaneous regression.2-7
Postnatal presentation is also variable as much as prenatal
clinical history.3,4 Symptoms range from respiratory distress
at birth with neonatal death to entirely asymptomatic lesions
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for recurrent pneumonias or spontaneous pneumothorax
during adulthood.
Surgical removal of the lesion is considered the gold
standard for all patients with CCAMs who became symp-
tomatic.5,7-9 However, the management of asymptomatic
lesions is still debated. Some authors advocate early inter-
vention to prevent possible complications later in life,
whereas others suggest a wait-and-see policy to avoid possi-
ble surgical complications.5,9,10
The aims of our study were to evaluate (1) whether chil-
dren surgically treated for symptomatic CCAMs have a dif-
ferent outcome compared with those undergoing operations
for asymptomatic lesions and (2) whether young age at the
time of the operation negatively affects the outcome.
MATERIALS AND METHODS
Medical records of all patients with CCAMs undergoing operations from
January 1988 to December 2005 were retrospectively reviewed with ap-
proval of our ethics review board. Selection criteria for the study were a his-
tologically proved CCAM with or without accessorial vessels, as for mixed
lesions. Patients affected by other lung malformations were excluded
(Figure 1). Preoperative evaluation consisted of routine blood examination,gery c October 2009
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cardiologic assessment, and chest radiographic analysis. All patients
underwent a preoperative thoracic computed tomographic scan to confirm
the diagnosis. All children underwent open lateral thoracotomy through
the fourth or fifth intercostal space, according to the site of the lesion. Stan-
dard antibiotics were administered, and a pleural drain was inserted at the
time of the operation. All specimens were histologically examined by a se-
nior pathologist to confirm the diagnosis.
Patients were stratified according to symptomatology before the opera-
tion: group A included all children undergoing operations when asymptom-
atic, whereas symptomatic children were enrolled in group B. Patients were
considered symptomatic when they presentedwith at least 1 of the following
symptoms: respiratory distress syndrome, dyspnea, cyanosis with no other
possible cause, recurrent pneumonia, asthmatic spells, and spontaneous
pneumothorax. Table 1 summarizes the clinical characteristics of the 2
groups.
The evaluated outcomes were as follows. First were the need and length
of postoperative mechanical ventilation. The need for mechanical ventila-
tion was established by a team of expert intensivists (parameters considered
to stop ventilation were a required fraction of inspired oxygen of 0.25,
a PaCO2 of less than 44 mm Hg, and a PaO2 of between 95 and 100 mm
Hg). Second were the occurrence and length of pleural drainage. Criteria
consistent with pleural drainage removal were complete re-expansion of
the lung and absence of pleural effusion at chest radiographic analysis 24
hours after closed drainage. Third was the length of postoperative hospital
stay. Fourth was the incidence of major postoperative complications (eg,
pleural effusion, hemothorax, and pneumothorax under tension). The final
evaluated outcome was the mortality rate.
A subsequent age-based stratification of all asymptomatic patients was
performed to assess whether age at the time of surgical intervention affects
the outcome. First, we considered a cutoff limit of 6 months of age at the
time of intervention because younger infants are generally considered at
increased risk for perioperative complications. Subsequently, an earlier
age limit at the time of the operation of 3 months was considered to better
understand the role of age on outcome. Patients in group B were not restra-
tified on the basis of age because, according to the literature,5,7-9 symptoms
have to be considered an indication for surgical intervention independently
from the age of the patients. Statistical analysis was performed with the
Fisher’s exact and Mann–Whitney tests. Calculation of odds ratios (ORs)
and 95% confidence intervals (CIs) was achieved for age-related risk of
symptom development.
RESULTS
Asymptomatic Versus Symptomatic Patients
Fifty-seven patients were consecutively treated from
January 1998 to December 2005. Thirty-five were asymp-
tomatic at the time of the operation (group A), whereas 22
presented with symptoms (group B). All infants enrolled
in group A had a prenatal suspicion of CCAM and were
evaluated throughout pregnancy up to the delivery, whereas
only 8 (36.3%) symptomatic patients had an antenatal diag-
nosis of ‘‘congenital cyst of the lung’’ (P< .05). Five of
these infants had symptoms in the first 10 days of life, 2The Journal of Thoracic and Cmore before 6 months of age, and only 1 at 5 years of age.
Symptoms observed were respiratory distress syndrome in
3 patients, recurrent pneumonia in 2 patients, and dyspnea
and cyanosis with no other cause in 3 patients. Notably,
analyzing age at the time of the operation, patients older
than 6 months of age were more likely to be symptomatic
at the time of the operation (OR, 5.317; 95% CI, 1.558–
18.145). At the time of the operation, all patients underwent
complete lobectomy (Table 1). In a symptomatic patient op-
erated on at 11 months of age, rhabdomyoblastic foci were
found within the lesion on microscopic analysis.
The need for postoperative mechanical ventilation was
similar for children enrolled in the study (P¼ .78); however,
longer sedation and mechanical ventilation were required for
patients with symptomatic CCAMs compared with those
with asymptomatic CCAMs (P ¼ .0016). Moreover, we
found that the lengths of pleural drainage and postoperative
hospital stay were significantly longer in symptomatic chil-
dren (P ¼ .0034 and P ¼ .0005, respectively). Patients
treated for symptomatic CCAMs presented with a higher
rate of major postoperative complications (P ¼ .02),
whereas the mortality rate did not shown any difference
between the 2 groups, with only 1 death observed in a symp-
tomatic infant undergoing an operation (right pneumonec-
tomy) during his first day of life for intractable respiratory
failure (Table 2).
Analysis of Age-Stratified Asymptomatic Babies
Patients in group Awere subsequently stratified according
to age at the time of the operation (6 or>6 months).
Twenty-seven infants underwent surgical intervention be-
fore 6 months of age, whereas only 8 children experienced
lobectomy later in life. No difference was found among
those 2 groups, except for age and weight at the time of
the operation. The need for and length of mechanical venti-
lation were similar (P ¼ .33 and P ¼ .42, respectively), as
was the duration of pleural drainage and the length of hospi-
tal stay (P ¼ .42 and P ¼ .06, respectively). No differences
in complication and mortality rates were observed (P ¼ 1.0
in both cases). Similar results were obtained when stratifying
asymptomatic babies undergoing operations before or after 3
months of age (Table 3).
DISCUSSION
CCAM is a rare congenital lesion of the lung that is usu-
ally limited to one pulmonary lobe and characterized by cys-
tic enlargement with adenomatoid appearance of the lung
parenchyma. The exact incidence in the general population
is still not well defined: the only 2 population-based reports
available in the literature found an incidence ranging ap-
proximately from 3/105 to 9/105.2,11 Data are derived largely
from tertiary care centers and might not reflect general pop-
ulation rates. In addition, at birth, CCAM is usually asymp-
tomatic and might be silent for years. This noiseless clinicalardiovascular Surgery c Volume 138, Number 4 827
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FIGURE 1. Selection flowchart. CT, Computed tomography; CCAM, congenital cystic adenomatoid malformation of the lung.behavior might be responsible for a high rate of hidden
morbidity of CCAM in the general population. Nonetheless,
antenatal diagnosis is increasingly reported because of
improvement in prenatal ultrasonographic screening.12
Prenatal suspicion has important consequences on maternal
and fetal ongoing care. Although the prognosis is good for
most of these babies, prenatal evolution of CCAMs can
TABLE 1. Patient characteristics
Group A Group B P value
No. of patients (%) 35 (61.4) 22 (38.6)
Prenatal diagnosis,
n (%)
35 (100) 8 (36.3) <.05
Sex (male/female) 12/23 11/11 NS
Age at intervention,
median (range)
213 d (1 d–5 y) 1140 d (1 d–14 y) <.05
Weight at intervention
(g), median (range)
6050 (2480–
16,000)
13,090 (2070–
43,000)
<.05
Lobectomies (right/left) Upper lobe: 3/6 Upper lobe: 5/5
Middle lobe: 1 Middle lobe: 1
Lower lobe: 15/10 Lower lobe: 3/8
NS, Not significant.828 The Journal of Thoracic and Cardiovascular Survary widely, from complete regression to the development
of fetal hydrops, which is nearly always fatal. This unpre-
dictable course of antenatally detected CCAMs should be
considered during prenatal counseling, and a close follow-
up during pregnancy is essential to allow appropriate feto-
maternal treatment.10
Delivery has to be planned in a tertiary care center only
for those fetuses presenting with factors worsening the
prognosis (eg, hydrops, severe mediastinal shift,
TABLE 2. Group A versus group B
Group A
(n ¼ 35)
Group B
(n ¼ 22)
P
value
No. of patients requiring ventilation 18 10 .78
Length of ventilation (d), median
(range)
1 (1–2) 2 (1–14) .0016
Length of pleural drainage (d), median
(range)
5 (3–10) 7.5 (3–31) .0034
Length of hospital stay (d), median
(range)
10 (6–68) 25.5 (1–87) .0005
Major complications (n) 4 9 .02
Deaths (n) 0 1 .38gery c October 2009
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Group A,
<6 mo (n ¼ 27)
Group A,
6 mo (n ¼ 8)
P
value
Group A,
<3 mo (n ¼ 19)
Group A,
3 mo (n ¼ 16)
P
value
No. of patients requiring ventilation 14 4 .33 9 9 .73
Length of ventilation (d), median (range) 1 (1–2) 1.5 (1–2) .42 1 (1–2) 1 (1–2) .62
Length of pleural drainage (d), median (range) 5.5 (4–10) 4.5 (3–7) .42 6 (4–10) 5 (3–8) .12
Length of hospital stay (d), median (range) 10 (7–68) 8.5 (6–11) .06 11 (7–68) 9.5 (6–16) .12
Major complications (n) 3 1 1.0 3 1 .61
Deaths (n) 0 0 1.0 0 0 1.0polyhydramnios, and large lesions).10 This approach guar-
antees an early perinatal evaluation, an easy admission to
the neonatal intensive care unit, and immediate surgical
treatment when necessary.
Principal Findings
In addition to antenatal evolution, the postnatal course can
be widely variable, from a complete asymptomatic lesion to
life-threatening symptomatic swelling. This unpredictable
behavior of CCAMs raised questions about the best surgical
timing for asymptomatic babies. Symptoms are generally
considered an indication for prompt CCAM surgical re-
moval,5,7-9 whereas the debate on the timing of surgical
treatment for asymptomatic patients still goes on. Our data
suggest that patients treated for symptomatic CCAMs expe-
rienced a longer and more complicated postoperative clini-
cal course. Those patients, compared with asymptomatic
patients, underwent longer mechanical ventilation, pleural
drainage stay, and hospitalization. Accordingly, different
authors reported a similar experience.3,5,9,13 Furthermore,
we found an increased risk of respiratory symptoms in
babies older than 6 months (OR, 5.317; 95% CI, 1.558–
18.145). Calvert and Lakhoo9 also found, in their series of
19 patients, a higher incidence of chronic inflammation/in-
fection on histology in patients treated at 6 months or older.
Those findings suggest performing elective surgical inter-
vention of antenatally diagnosed CCAMs before symptoms
develop. Conversely, some authors advocated conservative
management for asymptomatic CCAMs, given the risks of
surgical intervention and anesthesia in young children10 or
reporting the development of complications in ‘‘only’’
10% of asymptomatic CCAM lesions when left untreated.8
Our data demonstrate that young age at intervention (either
younger than 6 or even 3 months of age) do not negatively
affect postoperative outcome: asymptomatic patients under-
going operations at less than 6 or 3 months of age did not
have differences in complication rate, hospital stay, and
treatment required when compared with asymptomatic older
patients. This is consistent with other reports, in which no in-
creased risks were found in infants undergoing operations in
their first months of life.5,14 However, the reported 10% of
postoperative complications in asymptomatic patients might
be considered too high to be accepted. Nonetheless, it seemsThe Journal of Thoracic and Cthat, according to current knowledge, all asymptomatic pa-
tients will undergo an operation at some point in their lives
because of the development of symptoms. Consequently, all
patients left untreated will experience a theoretically higher
risk of major postoperative complications.
Parental psychologic distress might also be considered be-
cause it is increased by prenatal diagnosis of congenital
anomalies. Repeated consultations during pregnancy have
been shown to reduce parental anxiety15; however, Skari
and coworkers16 found that prenatal diagnosis of congenital
malformations was a significant independent predictor of
acute parental psychologic distress after birth. An early sur-
gical correction might reduce this stress and the correlated
parental anxiety.Moreover, early surgical removal of asymp-
tomatic CCAMs virtually abolishes any psychologic distress
of children treated later in life. Finally, some have suggested
early removal of asymptomatic lesions basedon the anecdotal
risk ofmalignancies associatedwith untreatedCCAMs.17We
do not consider such an approach effective, even if the rhab-
domyoblastic transformation was seen in an 11-month-old
baby with a symptomatic CCAM. Nonetheless, the possible
threat ofmalignancies later in life has to be reported to parents
during prenatal or postnatal counseling.
Recommendations
CCAM lesions should be surgically treated.5,7-9 In our se-
ries babies with symptomatic CCAMs faced more postopera-
tive complications, had a more intensive postsurgical course,
and experienced a longer hospital stay. Moreover, children
older than 6 months had an increased risk of becoming symp-
tomatic. On the other hand, nomajor risk of complication was
observed in babies operated on within 6 or even 3 months.
Therefore surgical removal of asymptomatic CCAMs at the
third or fourth month of age is safe, is effective, does not neg-
atively affect the outcome, and probably reduces the parental
psychologic distress. For those reasons, we suggest an early
elective operation for asymptomatic CCAMs.
Limitations
This study has an intrinsic limitation because it was de-
signed as a retrospective analysis and not as a prospective
randomized trial.ardiovascular Surgery c Volume 138, Number 4 829
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